Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0EG8X
|
|||
| Former ID |
DNC012077
|
|||
| Drug Name |
(1-Amino-3-methylsulfanyl-propyl)-phosphinic acid
|
|||
| Synonyms |
METHIONINE PHOSPHINATE; (1-AMINO-3-METHYLSULFANYL-PROPYL)-PHOSPHINIC ACID; MPJ; AC1O4QJ4; SCHEMBL4316253; ZINC29326788; DB04015; [(1R)-1-amino-3-methylsulfanylpropyl]-hydroxy-oxophosphanium; (R)-[(1R)-1-amino-3-(methylsulfanyl)propyl]phosphinic acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C4H11NO2PS+
|
|||
| Canonical SMILES |
CSCCC(N)[P+](=O)O
|
|||
| InChI |
1S/C4H10NO2PS/c1-9-3-2-4(5)8(6)7/h4H,2-3,5H2,1H3/p+1/t4-/m1/s1
|
|||
| InChIKey |
BSTOZABDPPHMGK-SCSAIBSYSA-O
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Aminopeptidase N (ANPEP) | Target Info | Inhibitor | [1] |
| BioCyc | Glutathione-mediated detoxification | |||
| KEGG Pathway | Glutathione metabolism | |||
| Metabolic pathways | ||||
| Renin-angiotensin system | ||||
| Hematopoietic cell lineage | ||||
| Pathwhiz Pathway | Glutathione Metabolism | |||
| Pathway Interaction Database | C-MYB transcription factor network | |||
| Reactome | Metabolism of Angiotensinogen to Angiotensins | |||
| WikiPathways | Metabolism of Angiotensinogen to Angiotensins | |||
| Cardiac Progenitor Differentiation | ||||
| miR-targeted genes in squamous cell - TarBase | ||||
| miR-targeted genes in muscle cell - TarBase | ||||
| miR-targeted genes in lymphocytes - TarBase | ||||
| miR-targeted genes in leukocytes - TarBase | ||||
| Glutathione metabolism | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Design of the first highly potent and selective aminopeptidase N (EC 3.4.11.2) inhibitor. Bioorg Med Chem Lett. 1999 Jun 7;9(11):1511-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.